Holdings of EQ/T.Rowe Price Health Sciences Portfolio
EQ Advisors Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 159M $ including 158.2M $ in equities, 99.5 %
- Positions
- 168 in 14 countries
- Top ten
- 40.0 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 17,620 | 16.2M $ | 10.20 % |
| 2 | Thermo Fisher Scientific Inc | 13,345 | 6.6M $ | 4.13 % |
| 3 | Intuitive Surgical Inc | 12,795 | 5.9M $ | 3.71 % |
| 4 | Stryker Corp | 17,093 | 5.6M $ | 3.53 % |
| 5 | Merck & Co Inc | 45,996 | 5.5M $ | 3.48 % |
| 6 | AstraZeneca PLC | 25,858 | 5.1M $ | 3.21 % |
| 7 | UnitedHealth Group Inc | 18,296 | 5M $ | 3.11 % |
| 8 | Argenx SE | 6,615 | 4.8M $ | 3.04 % |
| 9 | AbbVie Inc | 21,271 | 4.6M $ | 2.91 % |
| 10 | Regeneron Pharmaceuticals, Inc. | 5,583 | 4.3M $ | 2.71 % |
| 11 | Gilead Sciences Inc | 30,437 | 4.2M $ | 2.67 % |
| 12 | Johnson & Johnson | 16,135 | 3.9M $ | 2.48 % |
| 13 | Vertex Pharmaceuticals Inc | 8,804 | 3.9M $ | 2.47 % |
| 14 | Danaher Corp | 17,458 | 3.3M $ | 2.08 % |
| 15 | Alnylam Pharmaceuticals Inc | 8,096 | 2.7M $ | 1.69 % |
| 16 | Ascendis Pharma A/S | 10,163 | 2.3M $ | 1.46 % |
| 17 | Revolution Medicines Inc | 22,862 | 2.2M $ | 1.40 % |
| 18 | United Therapeutics Corp | 3,652 | 2.2M $ | 1.36 % |
| 19 | BeOne Medicines Ltd | 87,355 | 2M $ | 1.25 % |
| 20 | Roivant Sciences Ltd | 67,185 | 1.9M $ | 1.17 % |
| 21 | Protagonist Therapeutics Inc | 17,421 | 1.8M $ | 1.16 % |
| 22 | Insmed Inc | 10,628 | 1.7M $ | 1.09 % |
| 23 | Summit Therapeutics Inc | 90,599 | 1.7M $ | 1.08 % |
| 24 | Natera Inc | 8,505 | 1.7M $ | 1.07 % |
| 25 | Tenet Healthcare Corp | 8,917 | 1.7M $ | 1.06 % |
| 26 | Amgen Inc | 4,618 | 1.6M $ | 1.02 % |
| 27 | BrightSpring Health Services Inc | 37,764 | 1.6M $ | 1.01 % |
| 28 | Boston Scientific Corp | 24,374 | 1.5M $ | 0.96 % |
| 29 | HCA Healthcare Inc | 3,189 | 1.5M $ | 0.95 % |
| 30 | Guardant Health Inc | 15,907 | 1.5M $ | 0.92 % |
| 31 | CVS Health Corp | 19,718 | 1.4M $ | 0.89 % |
| 32 | Kymera Therapeutics Inc | 15,590 | 1.3M $ | 0.82 % |
| 33 | Cigna Group/The | 4,640 | 1.2M $ | 0.78 % |
| 34 | CG oncology Inc | 17,422 | 1.2M $ | 0.74 % |
| 35 | Cardinal Health, Inc. | 5,506 | 1.2M $ | 0.73 % |
| 36 | Krystal Biotech Inc | 4,323 | 1.1M $ | 0.70 % |
| 37 | Elevance Health Inc | 3,774 | 1.1M $ | 0.70 % |
| 38 | Scholar Rock Holding Corp | 21,192 | 1M $ | 0.66 % |
| 39 | Ionis Pharmaceuticals Inc | 13,552 | 1M $ | 0.64 % |
| 40 | Bridgebio Pharma Inc | 13,571 | 1M $ | 0.63 % |
| 41 | Structure Therapeutics Inc | 20,068 | 967.3K $ | 0.61 % |
| 42 | Chugai Pharmaceutical Co Ltd | 17,200 | 951.6K $ | 0.60 % |
| 43 | Celcuity Inc | 8,170 | 932.5K $ | 0.59 % |
| 44 | Praxis Precision Medicines Inc | 2,882 | 928.6K $ | 0.58 % |
| 45 | Royalty Pharma PLC | 19,273 | 924.5K $ | 0.58 % |
| 46 | CENTESSA PHARMACEUTICALS PLC | 22,606 | 897.9K $ | 0.56 % |
| 47 | Cencora Inc | 2,803 | 880.5K $ | 0.55 % |
| 48 | Vera Therapeutics Inc | 19,202 | 772.5K $ | 0.49 % |
| 49 | Apogee Therapeutics Inc | 8,836 | 743.7K $ | 0.47 % |
| 50 | Nuvalent Inc | 7,132 | 730.7K $ | 0.46 % |
| 51 | Abivax SA | 6,483 | 721.9K $ | 0.45 % |
| 52 | Edwards Lifesciences Corp | 8,786 | 703.6K $ | 0.44 % |
| 53 | Spyre Therapeutics Inc | 13,859 | 699K $ | 0.44 % |
| 54 | Incyte Corp | 7,207 | 678.3K $ | 0.43 % |
| 55 | Dianthus Therapeutics Inc | 8,036 | 674.4K $ | 0.42 % |
| 56 | Cytokinetics Inc | 10,227 | 674.1K $ | 0.42 % |
| 57 | Crinetics Pharmaceuticals Inc | 17,741 | 644.4K $ | 0.41 % |
| 58 | Madrigal Pharmaceuticals Inc | 1,198 | 627.1K $ | 0.39 % |
| 59 | Immunome Inc | 26,100 | 570.8K $ | 0.36 % |
| 60 | IQVIA Holdings Inc | 3,330 | 567.9K $ | 0.36 % |
| 61 | Kodiak Sciences Inc | 14,617 | 557.2K $ | 0.35 % |
| 62 | Belite Bio Inc | 3,300 | 526.2K $ | 0.33 % |
| 63 | Monte Rosa Therapeutics Inc | 31,015 | 510.2K $ | 0.32 % |
| 64 | Mirum Pharmaceuticals Inc | 5,221 | 482.3K $ | 0.30 % |
| 65 | Terns Pharmaceuticals Inc | 8,922 | 470.4K $ | 0.30 % |
| 66 | Moderna Inc | 8,753 | 444.7K $ | 0.28 % |
| 67 | Axsome Therapeutics Inc | 2,579 | 435.9K $ | 0.27 % |
| 68 | Alignment Healthcare Inc | 24,456 | 430.9K $ | 0.27 % |
| 69 | Oruka Therapeutics Inc | 8,482 | 416K $ | 0.26 % |
| 70 | Revvity Inc | 4,727 | 414.1K $ | 0.26 % |
| 71 | Beam Therapeutics Inc | 17,274 | 411.6K $ | 0.26 % |
| 72 | Alumis Inc | 18,625 | 410.3K $ | 0.26 % |
| 73 | West Pharmaceutical Services Inc | 1,600 | 401K $ | 0.25 % |
| 74 | Sonova Holding AG | 1,719 | 389.7K $ | 0.25 % |
| 75 | Sionna Therapeutics Inc | 9,555 | 383.1K $ | 0.24 % |
| 76 | IDEXX Laboratories Inc | 669 | 375.9K $ | 0.24 % |
| 77 | MBX Biosciences Inc | 12,465 | 372.1K $ | 0.23 % |
| 78 | Rhythm Pharmaceuticals Inc | 4,253 | 369.9K $ | 0.23 % |
| 79 | McKesson Corp | 416 | 360K $ | 0.23 % |
| 80 | ORIC Pharmaceuticals Inc | 28,225 | 357.6K $ | 0.23 % |
| 81 | Immunocore Holdings PLC | 11,527 | 347.5K $ | 0.22 % |
| 82 | Rapport Therapeutics Inc | 11,059 | 346K $ | 0.22 % |
| 83 | Caris Life Sciences Inc | 18,849 | 337K $ | 0.21 % |
| 84 | Nurix Therapeutics Inc | 21,324 | 330.5K $ | 0.21 % |
| 85 | Arrowhead Pharmaceuticals Inc | 5,261 | 329.9K $ | 0.21 % |
| 86 | Erasca Inc | 20,300 | 328.5K $ | 0.21 % |
| 87 | Billiontoone Inc | 4,058 | 320.3K $ | 0.20 % |
| 88 | Vaxcyte Inc | 5,352 | 311K $ | 0.20 % |
| 89 | Bio-Rad Laboratories Inc | 1,107 | 308.6K $ | 0.19 % |
| 90 | MoonLake Immunotherapeutics | 16,351 | 304.8K $ | 0.19 % |
| 91 | Palvella Therapeutics Inc | 2,375 | 296K $ | 0.19 % |
| 92 | Novo Nordisk A/S | 8,055 | 296K $ | 0.19 % |
| 93 | Centene Corp | 8,755 | 286.6K $ | 0.18 % |
| 94 | Celldex Therapeutics Inc | 8,612 | 273.2K $ | 0.17 % |
| 95 | Encompass Health Corp | 2,805 | 271.3K $ | 0.17 % |
| 96 | Stoke Therapeutics Inc | 8,292 | 270K $ | 0.17 % |
| 97 | Relay Therapeutics Inc | 25,532 | 254K $ | 0.16 % |
| 98 | Bicara Therapeutics Inc | 12,681 | 252.2K $ | 0.16 % |
| 99 | BEONE MEDICINES LTD | 839 | 249.2K $ | 0.16 % |
| 100 | Repligen Corp | 2,100 | 247.4K $ | 0.16 % |
Sector breakdown
- Health care 66.1 %
- Unattributed 33.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.7 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.2 %
The quoted currency of each line, as declared.
Country breakdown
- United States 86.9 %
- United Kingdom 3.3 %
- Netherlands 3.2 %
- Denmark 1.7 %
- Bermuda 1.3 %
- Hong Kong SAR China 1.3 %
- Cayman Islands 0.6 %
- Japan 0.6 %
- France 0.5 %
- Switzerland 0.2 %
- Singapore 0.2 %
- Germany 0.1 %
- Other countries 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 146 | 137.4M $ | 86.85 % |
| 2 | United Kingdom | 2 | 5.2M $ | 3.29 % |
| 3 | Netherlands | 3 | 5.1M $ | 3.24 % |
| 4 | Denmark | 2 | 2.6M $ | 1.66 % |
| 5 | Bermuda | 2 | 2.1M $ | 1.33 % |
| 6 | Hong Kong SAR China | 1 | 2M $ | 1.25 % |
| 7 | Cayman Islands | 4 | 957.2K $ | 0.61 % |
| 8 | Japan | 1 | 951.6K $ | 0.60 % |
| 9 | France | 2 | 830.4K $ | 0.53 % |
| 10 | Switzerland | 1 | 389.7K $ | 0.25 % |
| 11 | Singapore | 1 | 242.8K $ | 0.15 % |
| 12 | Germany | 1 | 200.6K $ | 0.13 % |
Cite this page
Titelia. "Holdings of EQ/T.Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000062644